StockRing.com   Home    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   
  iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   
 10/1/2014, (NASDAQ:PFE), $29.57 -0.20, -0.67%, "HOLD" Pfize Stock
 




  
  

PFE rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

On   10/1/2014   StockRing.com recommends to   "HOLD"   PFE   stock at current price of   $29.57.
Today PFE stock opened at $29.77 and was trading in the daily range of $ 290890 per share.
Pfize (NASDAQ:PFE) Market capitalization is $187.5B. PFE average daily volume is N/A.
On last trading session PFE stock traded 25,670,326 shares. Also the Short Ratio for (NASDAQ:PFE) stock is 50.327B.
Last year Pfize(NASDAQ:PFE) before taxes (EBITDA) (ttm) earned $29.59 on revenue of $2.46.
PFE 50-Day Moving Average is $21.826B vs. $29.57 now and 200-Day Moving Average is $29.43 vs. $29.57.
--------------------------------------------------------------------------------------------------------------------
VIX is "HOLD".  Nasdaq is "HOLD".  S&P 500 is "HOLD" on  5/16/2014
--------------------------------------------------------------------------------------------------------------------
PFE Earnings Per Share - EPS (ttm) is 1.59. PFE Stock Price Per Earnings ratio - P/E is 18.70.
Pfize(NASDAQ:PFE) stock pays a dividend of $ Inc. Comm" per share which is a yield of "NYSE"%.
On average analysts predict that One Year Target Estimated price for PFE stock is $29.98.
In the last 52 weeks PFE stock was trading in the range of $27.87 - 32.96.
 
 
  Our FREE iPhone App Buy-Sell-Hold ratings for 4568 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 5/16/2014 6:13:26 PM
2. DOW30+    Part 2    192 Stocks    Updated: 5/16/2014 6:18:11 PM
3. DOW30+    Part 3    193 Stocks    Updated: 5/16/2014 6:23:19 PM
4. DOW30+    Part 4    195 Stocks    Updated: 5/16/2014 6:27:30 PM
 
5. ENERGY    Part 1    188 Stocks    Updated: 5/30/2014 10:49:50 AM
6. ENERGY    Part 2    186 Stocks    Updated: 5/30/2014 10:45:38 AM
7. ENERGY    Part 3    196 Stocks    Updated: 5/30/2014 10:40:22 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 5/19/2014 11:03:20 PM
9. HEALTH    Part 2    138 Stocks    Updated: 5/19/2014 11:06:54 PM
 
10. FINANCE    Part 1    191 Stocks    Updated: 5/29/2014 9:02:46 AM
11. FINANCE    Part 2    190 Stocks    Updated: 5/29/2014 9:08:02 AM
12. FINANCE    Part 3    188 Stocks    Updated: 5/29/2014 9:13:08 AM
13. FINANCE    Part 4    188 Stocks    Updated: 5/29/2014 9:17:57 AM
14. FINANCE    Part 5    190 Stocks    Updated: 5/29/2014 9:22:59 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 5/22/2014 12:09:15 AM
16. SERVICE    Part 2    185 Stocks    Updated: 5/22/2014 12:10:17 AM
17. SERVICE    Part 3    183 Stocks    Updated: 5/22/2014 12:02:57 AM
18. SERVICE    Part 4    193 Stocks    Updated: 5/22/2014 12:07:53 AM
 
19. TECH    Part 1    187 Stocks    Updated: 5/20/2014 10:04:33 AM
20. TECH    Part 2    183 Stocks    Updated: 5/20/2014 10:10:24 AM
21. TECH    Part 3    184 Stocks    Updated: 5/20/2014 10:15:47 AM
22. TECH    Part 4    102 Stocks    Updated: 5/20/2014 10:27:15 AM
 
23. IPOs    200 Stocks    Updated:  TODAY , 6/10/2014 3:37:13 AM
 
24. ETFs    Part 1    193 Stocks    Updated: 5/16/2014 6:48:58 PM
25. ETFs    Part 2    191 Stocks    Updated: 5/16/2014 6:52:54 PM
26. ETFs    Part 3    157 Stocks    Updated: 5/16/2014 6:56:31 PM

BUY  DOW 30+: FF  FTK  PTEN  NR  EXH     ENERGY: ADMA  RNG  CDW  CBA  BLUE     HEALTH: ACWX  EPHE  FM  DVYA  AOM 
      FINANCE: XLK  DWX  BWZ  GII  SCPB     SERVICES: UST  MLPX  BRAQ  YCL  EMFM     TECH: CSGP  WDC  ONNN  RENN  JNPR 
SELL  DOW 30+: PVA  PWE  FOE  GNE  EOX     ENERGY: RMAX  SEAS  NBCB  PETX  VOYA     HEALTH: ITA  ICLN  EIRL  SCZ  PICK 
      FINANCE: XME  XSW  KBE  EWO  BAL     SERVICES: VIXM  EEV  UVXY  QID  AGQ     TECH: BRKR  CPHD  IPGP  LLTC  MDRX 


Samples of StockRing Real Time "Buy-Sell-Hold" stock Ratings:



  Enter Stock:  
  
    
    
 
 



Download StockRing Free  Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH

  Our FREE iPhone App Buy-Sell-Hold ratings for 4568 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 5/16/2014 6:13:26 PM
2. DOW30+    Part 2    192 Stocks    Updated: 5/16/2014 6:18:11 PM
3. DOW30+    Part 3    193 Stocks    Updated: 5/16/2014 6:23:19 PM
4. DOW30+    Part 4    195 Stocks    Updated: 5/16/2014 6:27:30 PM
 
5. ENERGY    Part 1    188 Stocks    Updated: 5/30/2014 10:49:50 AM
6. ENERGY    Part 2    186 Stocks    Updated: 5/30/2014 10:45:38 AM
7. ENERGY    Part 3    196 Stocks    Updated: 5/30/2014 10:40:22 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 5/19/2014 11:03:20 PM
9. HEALTH    Part 2    138 Stocks    Updated: 5/19/2014 11:06:54 PM
 
10. FINANCE    Part 1    191 Stocks    Updated: 5/29/2014 9:02:46 AM
11. FINANCE    Part 2    190 Stocks    Updated: 5/29/2014 9:08:02 AM
12. FINANCE    Part 3    188 Stocks    Updated: 5/29/2014 9:13:08 AM
13. FINANCE    Part 4    188 Stocks    Updated: 5/29/2014 9:17:57 AM
14. FINANCE    Part 5    190 Stocks    Updated: 5/29/2014 9:22:59 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 5/22/2014 12:09:15 AM
16. SERVICE    Part 2    185 Stocks    Updated: 5/22/2014 12:10:17 AM
17. SERVICE    Part 3    183 Stocks    Updated: 5/22/2014 12:02:57 AM
18. SERVICE    Part 4    193 Stocks    Updated: 5/22/2014 12:07:53 AM
 
19. TECH    Part 1    187 Stocks    Updated: 5/20/2014 10:04:33 AM
20. TECH    Part 2    183 Stocks    Updated: 5/20/2014 10:10:24 AM
21. TECH    Part 3    184 Stocks    Updated: 5/20/2014 10:15:47 AM
22. TECH    Part 4    102 Stocks    Updated: 5/20/2014 10:27:15 AM
 
23. IPOs    200 Stocks    Updated:  TODAY , 6/10/2014 3:37:13 AM
 
24. ETFs    Part 1    193 Stocks    Updated: 5/16/2014 6:48:58 PM
25. ETFs    Part 2    191 Stocks    Updated: 5/16/2014 6:52:54 PM
26. ETFs    Part 3    157 Stocks    Updated: 5/16/2014 6:56:31 PM

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App with Buy-Sell-Hold ratings for 4,030 stocks:

  iPhone App Buy-Sell-Hold Ratings for 5-5-2013
           
           
           
           
     
  

 
  Enter Stock:  
  
    
    
 



10/1/2014  Wednesday, October 01, 2014 (Irvine, California) Today StockRing.com Recommendation is to "HOLD"for Pfize (NASDAQ:PFE) Stock. PFE stock opening price was $29.77 per share. Current price of NASDAQ:PFE Stock is $29.57 per share and it is $-0.20, (-0.67%) today and it was trading in the daily range of $290890 per share. Current Bid Price for (NASDAQ:PFE) stock is $3.43 and the Ask Price is $29.52. In the last 52 weeks PFE stock was trading in the range of $27.87 - 32.96. 50-Day Moving Average for (NASDAQ:PFE) stock is $21.826B and 200-Day Moving Average is $29.43. On average analysts predict that One Year Target Estimated price for (NASDAQ:PFE) stock is $29.98.

Pfize (NASDAQ:PFE) is rated as a wait on 9/10/2014 1:26:20 AM.

Pfize (NASDAQ:PFE) Market capitalization is $187.5B. (NASDAQ:PFE) stock average daily volume is N/A shares per day. However, on last trading session of Sep 30, 2012 PFE stock traded 25,670,326 shares. Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:PFE) stock is 50.327B. On previous trading session PFE Stock closed at $29.77 per share.

Last year Pfize (NASDAQ:PFE) before taxes (EBITDA) (ttm) earned $29.59 on total revenue of $2.46. Earnings Per Share - EPS (ttm) for PFE stock is 1.59. Also, (NASDAQ:PFE) Stock Price Per Earnings ratio - P/E is 18.70. Thus, (NASDAQ:PFE) Stock Price/Sales (ttm) ratio is 34.02 and Price/Book (mrq) ratio is 3.75.

(NASDAQ:PFE) Stock pays a dividend of $ Inc. Comm" per share which is a yield of "NYSE"%. So at this time (NASDAQ:PFE) Stock maintains Trailing Annual Dividend Rate at 2.90.


StockRing Recommendations for Pfize (NASDAQ:PFE) Stock are updated daily here

http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=PFE

At this time StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a BUY or SUPER BUY rating. If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have a SELL or SUPER SELL rating.

If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech sectors on your iPhone, then please download Buy-Sell-Hold iPhone App here:


Free Limited or $10 Full Version  Buy-Sell-Hold iPhone App
for 1,200 stocks in Energy, Healthcare, Finance, Services and Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH


 
  Enter Stock:  
  
    
    
 
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

NASDAQ:PFE Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info

PFE rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

10/1/2014 1 Year Stock market price chart for Pfize (NASDAQ:PFE) Stock on Wednesday, October 01, 2014
  
1 Year PFE 1 Year Dow Jones
1 Year Nasdaq 1 Year S&P 500
10/1/2014 5 days Stock market price chart for Pfize (NASDAQ:PFE) Stock on Wednesday, October 01, 2014
  
5 Days PFE 5 Days Dow Jones
5 Days Nasdaq 5 Days S&P 500
  

EUROs for $1 DOLLAR: 30 days
     

NASDAQ:PFE Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

PFE rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

10/1/2014 Stock market price quote data for Pfize (NASDAQ:PFE) Stock on Wednesday, October 01, 2014

Last Trade: 29.57
Trade Time: Sep 30
Change: -0.20, (-0.67%)
Prev Close: 29.77
Open: 29.77
Bid: 3.43
Ask: 1.02
1y Target Est: $29.98
50-Day Moving Average: 21.826B
200-Day Moving Average:
29.43
Short Ratio: 50.327B
Trailing Annual Dividend Rate: 2.90
Day's Range: 290890
52wk Range: 27.87 - 32.96
Volume: 25,670,326
Avg Vol: N/A
Market Cap: 187.5B
P/E (ttm): 18.70
EPS (ttm): 1.59
Div & Yield: Inc. Comm" ("NYSE"%)
Revenue (ttm): 2.46
Earnings before Tax (EBITDA) (ttm): 29.59
Price/Sales (ttm): 34.02
Price/Book (mrq): 3.75
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

  
  
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

PFE rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

PFIZER INC(NYSE: PFE) Company Information

Pfizer Inc.
235 East 42nd Street
New York, NY 10017
United States - Map
Phone: 212-573-2323
Fax: 212-573-7851
Web Site: http://www.pfizer.com

PFIZER INC(NYSE: PFE) DETAILS

PFIZER INC(NYSE: PFE) Index Membership: Dow Jones Composite Dow Industrials S&P 100 S&P 500 S&P 1500 Super Comp
PFIZER INC(NYSE: PFE) Sector: Healthcare
PFIZER INC(NYSE: PFE) Industry: Drug Manufacturers - Major
PFIZER INC(NYSE: PFE) Full Time Employees: 75,400

PFIZER INC(NYSE: PFE) BUSINESS SUMMARY

Pfizer Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimer?s disease. It also provides Celebrex for arthritis pain, and inflammation and acute pain; Vfend for esophageal candidiasis and blood stream infections; Zyvox for bacterial infections; and Selzentry/Celsentri for adults infected with only CCR5-tropic HIV-1 detectable. In addition, this segment provides Viagra for erectile dysfunction; Detrol and Toviaz for overactive bladder; Camptosar for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and Genotropin for growth disorders. The company?s Animal Health segment offers parasiticides, anti-inflammatories, antibiotics, vaccines, antiemetics, and anti-obesity agents. It also provides Revolution/Stronghold for dogs and cats; Rimadyl for pain and inflammation associated with canine osteoarthritis and soft tissue orthopedic surgery; Clavamox/Synulox for skin and soft tissue infections; RespiSureOne/StellamuneOne to prevent pneumonia in swine; Bovi-Shield Gold for reproductive and respiratory protection; Dectomax, an injectable and pour-on formulations; Draxxin, an antibiotic for infections in cattle and swine; and Excede to treat infections in dairy cows, beef cattle, and swine. Pfizer Inc. also involves in contract manufacturing and bulk pharmaceutical chemicals businesses. It serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. The company was founded in 1849 and is headquartered in New York, New York.

PFIZER INC(NYSE: PFE) KEY EXECUTIVES

Mr. Jeffrey B. Kindler , 53 Chairman, Chief Exec. Officer, Chairman of Exec. Committee and Chairman of Exec. Compliance Committee $ 4.58M $ 0

Mr. Frank A. D'Amelio , 51 Chief Financial Officer, Sr. VP of Bus. Operations and Member of Exec. Compliance Committee $ 2.30M $ 0

Mr. Ian C. Read , 55 Group Pres of Worldwide Biopharmaceutical Bus.es and Member of Exec. Compliance Committee $ 2.30M $ 0

Mr. Martin Mackay , 52 Pres of PharmaTherapeutics R&D $ 2.29M $ 0

Mr. Natale S. Ricciardi , 60 Pres of Manufacturing N/A N/A



10/1/2014 Latest stock market news data for Pfize (NASDAQ:PFE) Stock on Wednesday, October 01, 2014

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

PFE rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

Should Pfizer Inc. Buy Actavis plc?
Motley Fool - Sep 25, 2014
Earlier this year, a media circus erupted over Pfizer's reported interest in AstraZeneca (NYSE: AZN ) . The deal would have exceeded $100 billion and created a company roughly the same size as Johnson & Johnson. AstraZeneca brass, however, felt the ...
Pfizer-Actavis Merger Still A Possibility - Bidness ETC
Pfizer Said to Approach Actavis to Gauge Interest in Deal - Bloomberg
Pfizer drug effective in patients with rare lung cancer, study shows
Fox News - Sep 29, 2014
Pfizer Inc's Xalkori, which treats lung cancer patients with a specific gene mutation, proved effective in shrinking tumors in those with an even rarer form of the disease, according to data presented at a medical meeting on Saturday.
Pfizer Announces Positive Data For Cancer Drug Xalkori - Bidness ETC
Pfizer Inc. Stock Fails To Break Out: Is It Headed Back Down?
Benzinga - Sep 29, 2014
Pfizer Inc. (NYSE: PFE) shareholders have experienced the short-term euphoria of seeing their stock rally a massive 10 percent from August to September.
Better Dividend Stock: Johnson & Johnson or Pfizer, Inc?
Motley Fool - Sep 29, 2014
According to Susanna Kim of ABC News, dividend yield and dividend growth comprised 90% of the total nominal returns for investors in the S&P 500 between 1910 and 2010.
Pfizer Inc.: Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology ...
The Wall Street Transcript - Sep 30, 2014
NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) and Kyowa Hakko Kirin (Tokyo:4151), announced today that they have entered into an agreement to explore the therapeutic potential of the combination of Pfizer's PF-05082566, ...
Can Pfizer Grow Without A Big Acquisition?
Seeking Alpha (registration) - Sep 29, 2014
With the deal likely off the table, investors need to evaluate whether Pfizer can grow without a big acquisition. Growth in its existing portfolio, combined with stronger profitability and fundamentals give the company the resources to provide a good ...
Why I'd Avoid Pfizer Inc. Stock Despite the Dividend
Motley Fool - Sep 11, 2014
Pfizer's problem in the clinic is uncertainty regarding its ability to generate new blockbuster drugs. The company decided, along with almost every other Big Pharma simultaneously, to go after novel oncology and high cholesterol drugs to replace former ...
Drugmaker Pfizer, aiming to raise sales of its Viagra, starts new ad campaign ...
Fox Business - 20 hours ago
Having a woman speak directly to men about impotence is a unique strategy for Pfizer Inc. The world's second-biggest drugmaker is looking for ways to boost sales of Viagra, Pfizer's No.
Stocks Alert: Pfizer Inc. (NYSE:PFE), Angie's List Inc (NASDAQ:ANGI), Oncomed ...
Equities Focus (registration) - 12 hours ago
Pfizer Inc. (NYSE:PFE) and Kyowa Hakko Kirin said late on Monday they signed an agreement to study the therapeutic potential of combining Pfizer's PF-05082566 antibody with Kyowa Hakko Kirin's anti-CCR4 antibody mogamulizumab in a Phase Ib clinical ...
Why Pfizer (PFE) Stock Is Down Today
TheStreet.com - Sep 23, 2014
To add to this, PFE has a quick ratio of 2.03, which demonstrates the ability of the company to cover short-term liquidity needs. The gross profit margin for PFIZER INC is currently very high, coming in at 85.17%. It has increased significantly from ...

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

PFE rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs


10/1/2014 News from StockRing Blog about Pfize (NASDAQ:PFE) Stock on Wednesday, October 01, 2014



Copyright © 2014 StockRing.com. All rights reserved.
Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds   Form

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.